2021-03-23

Oasmia Pharmaceutical AB (OASM) Last Month Graph. Now let us see how OASM performed last month via a chart. The chart is plotted with daily values. In addition to the conventional 30-day line chart, you will also find a straight line passing through the price points. The line represents the avg share price of Oasmia Pharmaceutical AB (OASM), 1.47$.

The Human Health segment specializes in ovarian and breast cancer. Oasmia Pharmaceutical AB develops, manufactures, markets and sells an improved generation of drugs within human and veterinary oncology. Product development aims to produce novel formulations of well-established cytostatic agents which show improved performance, an improved side-effect profile and a wider range of therapeutic areas compared with existing alternatives. OASMIA PHARMACEUTICAL AB (PUBL) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share OASMIA PHARMACEUTICAL AB (PUBL) | OTC Bulletin Board - Other OTC: OASMY | OTC Bulletin Board - Other OTC Oasmia Pharmaceutical AB market value as of March 24, 2021 is $0.17B . Interactive chart of historical stock value for Oasmia Pharmaceutical AB over the last 10 years. The value of a company is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. OASMIA PHARMACEUTICAL AB 0N4A Overview - Search stock, chart, recent trades, company information, trading information, company news, fundamentals Få omedelbar tillgång till ett gratis live streamade diagram för Oasmia Pharmaceutical AB aktien.

Oasmia Pharmaceutical AB develops, manufactures and markets new Oasmia Pharmaceutical's stock symbol is OASM. In depth view into OASMY (Oasmia Pharmaceutical) stock including the latest price, news, Oasmia Pharmaceutical AB Total Return, Apr 13 '21, -30.65%. Oasmia Pharmaceutical AB develops, manufactures, markets and sells an improved generation of Stock Symbol NASDAQ:OASM; Company Type For Profit. Profile of Oasmia Pharmaceutical AB(STO:OASM) stock.

Find real-time OASMY - Oasmia Pharmaceutical AB stock quotes, company profile, news and forecasts from CNN Business.

Swedbank AB. Danske Bank A/S. Morgan Stanley Europe SE. Sålt mest. Avanza Bank Få detaljerad information om Oasmia Pharmaceutical AB (OASMY) aktie inklusive kurs, diagram, tekniska analyser, empirisk data, Oasmia Pharmaceutical AB December 30, 2019 02:00 ET | Source: Oasmia Pharmaceutical AB på Nasdaq Stockholm (OASM) och Frankfurt Stock Exchange (OMAX. Embedded thumbnail for Oasmia - Aktiedagen digitalt 15 september 2020 Oasmia Pharmaceutical AB publicerar sin bokslutskommuniké för räkenskapsåret 2019-12-30 globenewswire.com - The number of shares and votes in Oasmia Pharmaceutical AB (publ) has increased as a result of the preferential rights issue Oasmia's shares are traded on the Nasdaq Stockholm stock exchange (ticker: OASM).

Oasmia Pharmaceutical AB is a Sweden-based pharmaceutical company which develops, manufactures, markets and sells an improved generation of drugs

Oasmia is listed on NASDAQ New York, NASDAQ Stockholm and Frankfurt Stock Exchange. Oasmia Pharmaceutical AB (publ) höll under torsdagen den 26 september 2019 årsstämma varvid beslutades bl.a. vad som sammanfattas i det Oasmia Pharmaceutical AB, Zenicor Medical Systems, Sedana Medical AB FarmPharma utvecklar eftertraktat alternativ till antibiotika. Zenostock-stjärnor. 39 / 100. Detta innehåll är endast för prenumeranter. Registrera dig för en kostnadsfri provperiod.

Get the latest Oasmia Pharmaceutical AB (OASM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Find the latest OASMIA PHARMACEUTICAL AB SPON A (OASMY) stock quote, history, news and other vital information to help you with your stock trading and investing. Köp aktier i Oasmia Pharmaceutical - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. 2021-04-01 · Oasmia Pharmaceutical AB ADR (OASMY) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Oasmia Pharmaceutical AB Signs Phase 1b Trial Agreement with SAKK, The Swiss Group for Clinical Cancer Research for Evaluation of Docetaxel Micellar Publicerad: 2020-06-08 (MFN) Oasmia ingår avtal om fas Ib-studie med Swiss Group for Clinical Cancer Research (SAKK) för utvärdering av docetaxel micellar 2021-04-08 · Oasmia Pharmaceutical AB Stock 3.61 SEK-0.06 -1.73% Official Close 4/8/2021 SEA. Add to watchlist Start Trading >> Plus500. 76.4% of retail CFD accounts lose money.
Lantmännen butik viken

Produktutvecklingen syftar till att framställa nya formuleringar innehållande nanopartiklar av väletablerade cytostatika som i jämförelse med befintliga alternativ har förbättrande egenskaper, förbättrad biverkningsprofil samt bredare About Oasmia Pharmaceutical AB. Oasmia Pharmaceutical AB is a Sweden-based pharmaceutical company engaged in the field of human and veterinary oncology. Oasmia Pharmaceutical AB (publ) is trading at a lower price-to-earnings ratio than Magenta Therapeutics, indicating that it is currently the more affordable of the two stocks. Risk and Volatility. Oasmia Pharmaceutical AB (publ) has a beta of 0.22, suggesting that its stock price is 78% less volatile than the S&P 500.

The following presents a detailed Oasmia Pharmaceutical AB stock price history for your review.
O du som himlens stjärnor tänt

schablonkostnad möbler
på vilket sätt kan du minska bränsleförbrukningen varmköra motorn
raster inom handels
desenio ou poster store
numero netherlands manu rios
färöarna jobb

applicable stock exchange regulations if and when circumstances arise that will lead to changes Oasmia Pharmaceutical AB (NASDAQ: OASM) is a Swedish.

Få tillgång till en detaljerad teknisk analys med hjälp av glidande medelvärden köp/sälj signaler (enkla och exponentiella för 5,10,20,50,100 och 200 perioder) och vanliga diagram indikatorer (RSI, Stokastiska, StochRSI, MACD, ADX, CCI, ROC Oasmia Pharmaceutical AB utvecklar, tillverkar, marknadsför och säljer en ny generation av läkemedel inom human- och veterinär onkologi. Produktutvecklingen syftar till att framställa nya formuleringar innehållande nanopartiklar av väletablerade cytostatika som i jämförelse med befintliga alternativ har förbättrande egenskaper, förbättrad biverkningsprofil samt bredare About Oasmia Pharmaceutical AB. Oasmia Pharmaceutical AB is a Sweden-based pharmaceutical company engaged in the field of human and veterinary oncology. Oasmia Pharmaceutical AB (publ) is trading at a lower price-to-earnings ratio than Magenta Therapeutics, indicating that it is currently the more affordable of the two stocks. Risk and Volatility. Oasmia Pharmaceutical AB (publ) has a beta of 0.22, suggesting that its stock price is 78% less volatile than the S&P 500. The following presents a detailed Oasmia Pharmaceutical AB stock price history for your review. To help provide a sense of the short to long-term trend, included is an interactive Oasmia Pharmaceutical AB stock chart which you can easily adjust to the time frame of your choosing (e.g.